Efficacy Study of the Effect of Budesonide on Emphysema

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhaler

NCT00868426 ·Status: COMPLETED ·Phase: PHASE1

Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol

NCT01555099 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD)

NCT00837629 ·Status: COMPLETED

A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With a Next-Generation Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

NCT05573464 ·Status: COMPLETED ·Phase: PHASE3

Phase I Pharmacokinetic Study (BF-BLOCK)

NCT01423305 ·Status: COMPLETED ·Phase: PHASE1

Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer

NCT00321893 ·Status: COMPLETED ·Phase: PHASE2

Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.

NCT04078126 ·Status: COMPLETED ·Phase: PHASE3

Comparison Between Symbicort® and Prednisolone in COPD

NCT00259779 ·Status: COMPLETED ·Phase: PHASE3

Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol

NCT00569712 ·Status: COMPLETED ·Phase: PHASE1

A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)

NCT00175747 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD Patients

NCT00483743 ·Status: COMPLETED ·Phase: PHASE2

The Effects of Inhaled Budesonide-formoterol-glycopyrronium in Moderate-to-severe COPD

NCT04675463 ·Status: UNKNOWN ·Phase: NA

Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation

NCT01560689 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/Formoterol

NCT01023516 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD

NCT00476099 ·Status: COMPLETED ·Phase: PHASE3

Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo

NCT01760304 ·Status: TERMINATED ·Phase: PHASE4

Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics

NCT02682862 ·Status: COMPLETED ·Phase: PHASE4

A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD

NCT00215436 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers

NCT01181063 ·Status: COMPLETED ·Phase: PHASE1

The Role of Nebulized Budesonide in the Treatment of Acute Exacerbations of COPD

NCT00274222 ·Status: TERMINATED

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

NCT06283966 ·Status: RECRUITING ·Phase: PHASE3

Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

NCT01646424 ·Status: COMPLETED

Efficacy of Budesonide-Formoterol in Bronchiectasis

NCT00728715 ·Status: COMPLETED ·Phase: NA

Pharmacokinetic Pilot Study on Budesonide/Formoterol

NCT01457716 ·Status: COMPLETED ·Phase: NA

Phase IV O2 Consumption Study in COPD Patients.

NCT02533505 ·Status: COMPLETED ·Phase: PHASE4